Get startedLog in
    Picture of Johnson & Johnson logo

    JNJ — Johnson & Johnson News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    Brief: New Tremfya® Study Shows Consistent Perianal Fistula Remission Across Key Crohn's Disease Patient Subgroups

    Picture of Johnson & Johnson logoJohnson & Johnson
    12/10/2026 22:37
    BRIEF-New Tremfya® Study Shows Consistent Perianal Fistula Remission Across Key Crohn's Disease Patient Subgroups
    Oct 12 (Reuters) - Johnson & Johnson JNJ.N:
    • NEW TREMFYA® (GUSELKUMAB) STUDY SHOWS CONSISTENT PERIANAL FISTULA REMISSION ACROSS KEY CROHN'S DISEASE PATIENT SUBGROUPS
    Source text: ID:nPn488jTKa
    Further company coverage: JNJ.N

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Johnson & Johnson

    See all news